Skip to content

Research of the dynamic coupling mechanism of the GAF triad in TKA

Research of the dynamic coupling mechanism of the GAF triad in TKA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110520
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-10-15
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Knee Arthroplasty

Interventions

robot-assisted total knee arthroplasty (TKA) combined with a balance solver:None

Sponsors

Beijing Jishuitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age 18–80 years, any sex. 2.Diagnosed with knee osteoarthritis and, after failure of conservative treatment, scheduled for primary unilateral total knee arthroplasty (TKA). 3.Primary unilateral TKA confirmed by the investigators upon a second review. 4.Preoperative evaluation shows no major comorbidities or other contraindications to surgery. 5.The subject fully understands the potential benefits and risks of the study, is willing to participate, and has signed informed consent.

Exclusion criteria

Exclusion criteria: Exclusion Criteria (any one of the following): 1.History of fracture or prior surgery involving the knee, femur, or tibia; 2.Knee tumor or other conditions requiring non-routine knee arthroplasty; 3.Moderate or greater deformity of the operative knee (e.g., varus/valgus, flexion contracture) and/or joint ankylosis; 4.Concomitant pathology of the hip or ankle; 5.Contraindications to TKA or severe systemic disease (cardiac, pulmonary, hepatic, renal, hematologic, etc.) precluding surgery; 6.Knee infection or revision TKA candidates; 7.Body mass index (BMI) > 40 kg/m^2; 8.Language barriers or inability to complete required assessments/scales; 9.Severe neuromuscular diseases; 10.Neuropathy affecting the operative limb; 11.Psychiatric disorders; 12.Missing case records or imaging data, or patients lost to follow-up; 13.Participation in another drug or device clinical study with endpoint reached within the past 3 months (i.e., insufficient washout); 14.Any other condition that, in the opinion of the investigators, makes the patient unsuitable for this clinical study.

Design outcomes

Primary

MeasureTime frame
Clinical Functional Scores;

Secondary

MeasureTime frame
Readmission rate;Radiographic measurements;

Countries

China

Contacts

Public ContactWu Xiangdong

Beijing Jishuitan Hospital, Capital Medical University

wxd561@gmail.com+86 10 5851 6688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026